Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab

We report a case of long-term survival with complete response of liver metastases within RAINBOW, a randomized, controlled trial of ramucirumab 8 mg/kg intravenously (days 1, 15) versus placebo, both plus paclitaxel 80 mg/m(2) intravenously (days 1, 8, 15), every 4 weeks in patients with previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil-Delgado, Maria Angeles, Lucidarme, Olivier, Bachet, Jean Baptiste, Mahi, Naima, Khayat, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167727/
https://www.ncbi.nlm.nih.gov/pubmed/30283289
http://dx.doi.org/10.1159/000490906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167727/
https://www.ncbi.nlm.nih.gov/pubmed/30283289
http://dx.doi.org/10.1159/000490906

Ejemplares similares